Anti-Thymocyte Globulin Prophylaxis Induces a Decrease in Naive Th Cells to Inhibit the Onset of Chronic Graft-versus-Host Disease: Results from the Canadian Bone Marrow Transplant Group (CBMTG) 0801 Study-Reference-Cited by-同舟云学术

Anti-Thymocyte Globulin Prophylaxis Induces a Decrease in Naive Th Cells to Inhibit the Onset of Chronic Graft-versus-Host Disease: Results from the Canadian Bone Marrow Transplant Group (CBMTG) 0801 Study

Published:2020-03 Issue:3 Volume:26 Page:438-444
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Naeije Leonie,Kariminia Amina^ORCID,Abdossamadi Sayeh,Azadpour Shima,Subrt Peter^ORCID,Kuzeljevic Boris^ORCID,Irvine Michael A.,Walker Irwin,Schultz Kirk R.

Funder

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference24 articles.

1. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study;Fraser;Blood,2006

2. Graft-versus-host disease;Ferrara;Lancet,2009

3. increasing incidence of chronic graft-versus-host disease in allogeneic transplantation—a report from CIBMTR;Arai;Biol Blood Marrow Transplant,2015

4. Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model;Preville;Transplantation,2001

5. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond;Mohty;Leukemia,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of different allo-Treg/allo-NK ratios on graft-versus-host disease in transplanted mice;Transplant Immunology;2023-10

2. Immunopathogenic mechanisms and modulatory approaches to graft-versus-host disease prevention in acute myeloid leukaemia;Best Practice & Research Clinical Haematology;2023-06

3. Controversies and expectations for the prevention of GVHD: A biological and clinical perspective;Frontiers in Immunology;2022-11-23

4. Chronic GvHD NIH Consensus Project Biology Task Force: Evolving path to personalized treatment of chronic GvHD;Blood Advances;2022-11-02

5. Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review;Frontiers in Immunology;2022-10-25